About the Authors

Ken Matsui

Affiliation Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Joseph W. Adelsberger

Affiliation AIDS Monitoring Laboratory, Clinical Service Program, Applied and Developmental Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Troy J. Kemp

Affiliation Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Michael W. Baseler

Affiliation AIDS Monitoring Laboratory, Clinical Service Program, Applied and Developmental Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Julie E. Ledgerwood

Affiliation Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

Ligia A. Pinto

pintol@mail.nih.gov

Affiliation Human Papillomavirus (HPV) Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: KM TJK LAP. Performed the experiments: KM JWA. Analyzed the data: KM JWA TJK LAP. Contributed reagents/materials/analysis tools: JWA MWB JEL. Wrote the paper: KM TJK LAP. Conducted the VRC 902 Study: JEL. Reviewed the data and read the manuscript: KM JWA TJK MWB JEL LAP. Oversight of the study: LAP.